An Analysis of the Interactions Between Individual Comorbidities and Their Treatments—Implications for Guidelines and Polypharmacy
Background
With aging there is an increase in frailty and chronic disease leading to a potential increase in medication use. Most clinical trials have excluded old, frail individuals and have failed to take into account the effects of outcome interaction.
Methods and Results
In this article we provide a mathematical model demonstrating that comorbidities, including old age, interact with therapies, reducing their effectiveness.
Conclusion
These findings question the validity of single disease guidelines in old persons or in persons with multiple chronic diseases.
To access this article, please choose from the options below
The authors have declared they have no conflicts of interest.
PII: S1525-8610(10)00184-2
doi:10.1016/j.jamda.2010.05.008
© 2010 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
